In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients

  • Microbiol Spectr. 2023 Nov 20:e0304723. doi: 10.1128/spectrum.03047-23.
Marguerite L Monogue  1  2 ,  Dhara Desai  3 ,  Christine A Pybus  3 ,  James M Sanders  1  2 ,  Andrew E Clark  4 ,  David E Greenberg  2  3
Affiliations
  • 1. Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • 2. Department of Internal Medicine, Infectious Diseases, and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • 3. Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • 4. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
PMID: 37982634 DOI: 10.1128/spectrum.03047-23
Keywords
Pseudomonas aeruginosa; cefiderocol; cystic fibrosis; in vitro.
Products